Patent and Trademark Office Notices  Patent and Trademark Office Notices
16, 2011 Wayne Jeffrey Perry Therapeutic Agent For Intranasal Administration And Method Of Making And Using Same 13/235,018 Sep ... 16, 2011 Wayne Jeffrey Perry Therapeutic Agent For Intranasal Administration And Method Of Making And Using Same 13/270,861 Oct ... Any inquiries concerning this notice may be directed to Bryan Lin, Office of PCT Legal Administration, at 571-272-3303, or via ... It is preferred that such initial requests be hand-carried to: Office of Patent Legal Administration Room MDW 7D55 600 Dulany ...
more infohttps://www.uspto.gov/web/offices/com/sol/og/2013/week08/TOC.htm
Intranasal Administration of Hsp70: Molecular and Therapeutic Consequences | SpringerLink  Intranasal Administration of Hsp70: Molecular and Therapeutic Consequences | SpringerLink
2014). Intranasal administration as a route for drug delivery to the brain: Evidence for a unique pathway for albumin. The ... Evgen'ev M.B., Garbuz D.G., Morozov A.V., Bobkova N.V. (2018) Intranasal Administration of Hsp70: Molecular and Therapeutic ... Taken together, our findings establish intranasal administration of exogenous human Hsp70 as a practical therapeutic approach ... 2008). Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and ...
more infohttps://link.springer.com/chapter/10.1007%2F978-3-319-89551-2_16
Patent US5112804 - Pharmaceutical composition and method of intranasal administration - Google Patents  Patent US5112804 - Pharmaceutical composition and method of intranasal administration - Google Patents
A composition and method for nasal administration of pharmaceuticals utilizes glycyrrhetinic acid as an absorption enhancer. ... The intranasal administration of vitamin B-12 is illustrated as follows.. 1 ml of a vitamin B-12 solution containing 1,000μg/ml ... The intranasal administration of human ACTH is illustrated as follows.. A 0.5% (w/v) 18β-glycyrrhetinic acid vehicle solution ... Pharmaceutical preparations for intranasal administration. US5989582 *. 14 Feb 1996. 23 Nov 1999. Weg; Stuart L.. ...
more infohttp://www.google.com.au/patents/US5112804
Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal Administration |...  Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal Administration |...
We evaluated the brain distribution of coumarin, acting as a model chemical, after intravenous or intranasal administration of ... The amount of coumarin in the brain after intranasal administration was significantly higher than that after intravenous ... Finally, we determined the brain distribution and biodistribution after intranasal administration of coumarin-loaded MPEG-PCL- ... Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal Administration. ...
more infohttps://link.springer.com/article/10.1007%2Fs11095-011-0440-7
Intragastric and Intranasal Administration of Lactobacillus paracasei NCC2461 Modulates Allergic Airway Inflammation in Mice  Intragastric and Intranasal Administration of Lactobacillus paracasei NCC2461 Modulates Allergic Airway Inflammation in Mice
... ... We aimed at testing the immunomodulatory effects of intranasal versus intragastric administration of Lactobacillus paracasei ... A concerted selection of intervention schedule, doses, and administration routes (intranasal versus intragastric) may markedly ... Intranasal L. paracasei NCC2461 efficiently protected sensitized mice upon exposure to OVA aerosols in a dose-dependent manner ...
more infohttps://www.hindawi.com/journals/iji/2012/686739/abs/
Study of the Tolerability of Ketorolac Tromethamine Following Intranasal Administration in Healthy Volunteers - Full Text View ...  Study of the Tolerability of Ketorolac Tromethamine Following Intranasal Administration in Healthy Volunteers - Full Text View ...
Study of the Tolerability of Ketorolac Tromethamine Following Intranasal Administration in Healthy Volunteers. The safety and ... Study of the Tolerability of Formulations of Ketorolac Tromethamine Following Intranasal Administration in Healthy Volunteers. ... Following administration of each treatment, subjects completed a visual analogue scale (VAS) (ranging from 'no discomfort' to ' ... In Part B subjects were randomized to receive a single intranasal dose of 15 mg ketorolac tromethamine containing 0% lidocaine ...
more infohttps://clinicaltrials.gov/ct2/show/NCT01363063?intr=ketorolac&
Molecules | Free Full-Text | Identification of Absorbed Constituents in the Rabbit Plasma and Cerebrospinal Fluid after...  Molecules | Free Full-Text | Identification of Absorbed Constituents in the Rabbit Plasma and Cerebrospinal Fluid after...
... after intranasal administration of Asari Radix et Rhizoma (AR). In total, 47 absorbed AR constituents including 14 monoterpenes ... and comprehensively analyze the absorbed constituents after intranasal administration of TCM. These findings extend our ... Keywords: nasal therapy; Asarum heterotropoides var. mandshuricum; intranasal administration; effective substance; ... Identification of Absorbed Constituents in the Rabbit Plasma and Cerebrospinal Fluid after Intranasal Administration of Asari ...
more infohttps://www.mdpi.com/1420-3049/19/4/4857
Molecules | Free Full-Text | Identification of Absorbed Constituents in the Rabbit Plasma and Cerebrospinal Fluid after...  Molecules | Free Full-Text | Identification of Absorbed Constituents in the Rabbit Plasma and Cerebrospinal Fluid after...
... after intranasal administration of Asari Radix et Rhizoma (AR). In total, 47 absorbed AR constituents including 14 monoterpenes ... and comprehensively analyze the absorbed constituents after intranasal administration of TCM. These findings extend our ... Keywords: nasal therapy; Asarum heterotropoides var. mandshuricum; intranasal administration; effective substance; ... Identification of Absorbed Constituents in the Rabbit Plasma and Cerebrospinal Fluid after Intranasal Administration of Asari ...
more infohttp://www.mdpi.com/1420-3049/19/4/4857
Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate - Full Text View -...  Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate - Full Text View -...
Must be able to cease treatment with intranasal medications including, but not limited to, intranasal steroids, intranasal ... Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate. The safety and ... The primary objective of this study is to compare the efficacy of intranasal administration of 100, 200, and 400 μg of ... Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone ...
more infohttps://clinicaltrials.gov/ct2/show/NCT01624662?term=optinose&rank=4
Frontiers | Intranasal Administration of Insulin Reduces Chronic Behavioral Abnormality and Neuronal Apoptosis Induced by...  Frontiers | Intranasal Administration of Insulin Reduces Chronic Behavioral Abnormality and Neuronal Apoptosis Induced by...
These findings suggest that intranasal insulin administration could be an effective approach to prevent the increased risk of ... These findings suggest that intranasal insulin administration could be an effective approach to prevent the increased risk of ... Importantly, insulin administered through intranasal delivery prior to anesthesia was found to prevent the anesthesia-induced ... Importantly, insulin administered through intranasal delivery prior to anesthesia was found to prevent the anesthesia-induced ...
more infohttps://www.frontiersin.org/articles/10.3389/fnins.2019.00706/full
NZ222907A - Preparation for intranasal administration containing a phospholipid absorption enhancing system 
      - Google...  NZ222907A - Preparation for intranasal administration containing a phospholipid absorption enhancing system - Google...
intranasal administration. absorption enhancing. administration containing. enhancing system. Prior art date. 1986-12-16. ... Device for intranasal administration UY32514A (en) 2009-03-27. 2010-10-29. Glaxo Group Ltd. MERGERS & Conjugates of a drug ... Insulin preparation for intranasal administration NL193099C (en) * 1981-10-30. 1998-11-03. Novo Industri As. Stabilized insulin ... Therapeutic compositions for intranasal administration comprising ketorolac. DK36492D0 (en) * 1992-03-19. 1992-03-19. Novo ...
more infohttps://patents.google.com/patent/NZ222907A/en
Activity-Dependent Neurotrophic Factor: Intranasal Administration of Femtomolar-Acting Peptides Improve Performance in a Water...  Activity-Dependent Neurotrophic Factor: Intranasal Administration of Femtomolar-Acting Peptides Improve Performance in a Water...
Activity-Dependent Neurotrophic Factor: Intranasal Administration of Femtomolar-Acting Peptides Improve Performance in a Water ... Activity-Dependent Neurotrophic Factor: Intranasal Administration of Femtomolar-Acting Peptides Improve Performance in a Water ... Activity-Dependent Neurotrophic Factor: Intranasal Administration of Femtomolar-Acting Peptides Improve Performance in a Water ... Activity-Dependent Neurotrophic Factor: Intranasal Administration of Femtomolar-Acting Peptides Improve Performance in a Water ...
more infohttp://jpet.aspetjournals.org/content/293/3/1091/tab-e-letters
GMS | 65th Annual Meeting of the German Society of Neurosurgery (DGNC) | Intranasal administration of neural stem cell-mediated...  GMS | 65th Annual Meeting of the German Society of Neurosurgery (DGNC) | Intranasal administration of neural stem cell-mediated...
Intranasal administration of neural stem cell-mediated enzym/prodrug therapy using a novel HSV-thymidine kinase variant ... Those receiving additional intranasal administration of NSC-TK007 displayed a significant tumor growth inhibition of 81% versus ... Here, we demonstrate that the non-invasive intranasal administration of tumor-targeting NSC is able to deliver a novel suicide ... Therapeutic effects of intratumoral (3x105 cells) and intranasal (1.5x106) NSC-TK007 application alone and the sequential ...
more infohttp://www.egms.de/static/en/meetings/dgnc2014/14dgnc280.shtml
RePub, Erasmus University Repository:
  Intranasal administration of oxytocin decreases task-related aggressive responses in...  RePub, Erasmus University Repository: Intranasal administration of oxytocin decreases task-related aggressive responses in...
Intranasal administration of oxytocin decreases task-related aggressive responses in healthy young males. Publication. ... Intranasal administration of oxytocin decreases task-related aggressive responses in healthy young males. ... In this randomized double-blind, placebo-controlled study, the effects of intranasal oxytocin (32IU) on taskrelated aggressive ... Our results indicate that oxytocin administration reduces aggressive behavior in healthy young men. Moreover, increased ...
more infohttps://repub.eur.nl/pub/118781
Intranasal Administration of an Inactivated Yersinia pestis Vaccine with Interleukin-12 Generates Protective Immunity against...  Intranasal Administration of an Inactivated Yersinia pestis Vaccine with Interleukin-12 Generates Protective Immunity against...
Intranasal Administration of an Inactivated Yersinia pestis Vaccine with Interleukin-12 Generates Protective Immunity against ... Intranasal Administration of an Inactivated Yersinia pestis Vaccine with Interleukin-12 Generates Protective Immunity against ... Intranasal Administration of an Inactivated Yersinia pestis Vaccine with Interleukin-12 Generates Protective Immunity against ... Intranasal Administration of an Inactivated Yersinia pestis Vaccine with Interleukin-12 Generates Protective Immunity against ...
more infohttps://cvi.asm.org/content/18/11/1925
Administration, Intranasal | Profiles RNS  Administration, Intranasal | Profiles RNS
Intranasal" by people in this website by year, and whether "Administration, Intranasal" was a major or minor topic of these ... "Administration, Intranasal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH ( ... Below are the most recent publications written about "Administration, Intranasal" by people in Profiles. ... Below are MeSH descriptors whose meaning is more general than "Administration, Intranasal". ...
more infohttps://profiles.rush.edu/display/21970
Administration, Intranasal | The Chopra Library  Administration, Intranasal | The Chopra Library
Could intranasal oxytocin be used to enhance relationships? Research imperatives, clinical policy, and ethical considerations. ... This is the first experimental study on the effect of oxytocin administration on the neural processing of facial stimuli ... The impact of oxytocin administration and maternal love withdrawal on event-related potential (ERP) responses to emotional ... we studied the effects of 16 IU of intranasal oxytocin on ERPs to pictures combining performance feedback with emotional facial ...
more infohttp://isharonline.org/tags/administration-intranasal
Molecular Mechanisms of Induction of Antigen-Specific Allograft Tolerance by Intranasal Peptide Administration | The Journal of...  Molecular Mechanisms of Induction of Antigen-Specific Allograft Tolerance by Intranasal Peptide Administration | The Journal of...
We have previously shown that intranasal (i.n.) administration of a single MHC class II-restricted HY peptide to female mice ... Molecular Mechanisms of Induction of Antigen-Specific Allograft Tolerance by Intranasal Peptide Administration. Katy Derbyshire ... Molecular Mechanisms of Induction of Antigen-Specific Allograft Tolerance by Intranasal Peptide Administration ... Molecular Mechanisms of Induction of Antigen-Specific Allograft Tolerance by Intranasal Peptide Administration ...
more infohttp://www.jimmunol.org/content/early/2011/04/12/jimmunol.1002444
Intranasal administration of acetylcholinesterase inhibitors | BMC Neuroscience | Full Text  Intranasal administration of acetylcholinesterase inhibitors | BMC Neuroscience | Full Text
Intranasal drug delivery is an effective option for the treatment of Alzheimer's disease and other central nervous system ... and opportunities for intranasal acetylcholinesterases, in particular galantamine. An in vitro screening model facilitated the ... Liu XF, Fawcett JR, Throne RG, DeFor TA, Frey WH: Intranasal administration of insulin-like growth factor-I bypasses the blood- ... Wang D, Gao Y, Yun L: Study on brain targeting of raltitrexed following intranasal administration in rats. Cancer Chemother ...
more infohttps://bmcneurosci.biomedcentral.com/articles/10.1186/1471-2202-9-S3-S6
Intranasal administration of acetylcholinesterase inhibitors | BMC Neuroscience | Full Text  Intranasal administration of acetylcholinesterase inhibitors | BMC Neuroscience | Full Text
Intranasal drug delivery is an effective option for the treatment of Alzheimer's disease and other central nervous system ... and opportunities for intranasal acetylcholinesterases, in particular galantamine. An in vitro screening model facilitated the ... Liu XF, Fawcett JR, Throne RG, DeFor TA, Frey WH: Intranasal administration of insulin-like growth factor-I bypasses the blood- ... Wang D, Gao Y, Yun L: Study on brain targeting of raltitrexed following intranasal administration in rats. Cancer Chemother ...
more infohttps://0-bmcneurosci-biomedcentral-com.brum.beds.ac.uk/articles/10.1186/1471-2202-9-S3-S6
Preferential Brain Homing following Intranasal Administration of Trypanosoma cruzi▿ - CORE  Preferential Brain Homing following Intranasal Administration of Trypanosoma cruzi▿ - CORE
Preferential Brain Homing following Intranasal Administration of Trypanosoma cruzi▿ By Kacey Caradonna and Mercio PereiraPerrin ...
more infohttps://core.ac.uk/display/8274082
Mucosal Atomization Devices Market - Delivering a Revolutionary Solution to Intranasal Drug Administration  Mucosal Atomization Devices Market - Delivering a Revolutionary Solution to Intranasal Drug Administration
... Pharmaceutical ... Intranasal Drug Delivery - Away from Needles. In the current scenario, although needle-based injections are the most common ... Further, as emerging intranasal delivery technologies eliminate the use of needles, there is no risk of needle-stick problems. ... The shortcomings of needle-based injections along with fear among patients has led to the onset of novel needleless intranasal ...
more infohttps://www.futuremarketinsights.com/reports/mucosal-atomization-devices-market
Intranasal administration of cationic liposomes enhanced granulocyte-macrophage colony-stimulating factor expression and this...  Intranasal administration of cationic liposomes enhanced granulocyte-macrophage colony-stimulating factor expression and this...
Here, we show that, although intranasal vaccination with cationic liposomes in combination with antigenic protein elicited GM- ... CSF expression at the site of administration, blocking GM-CSF function by using an anti-GM-CSF neutralizing antibody did not ... 1a, intranasal administration with OVA and DOTAP/DC-chol liposomes significantly exerted the expression of GM-CSF in nasal ... As expected, intranasal administration with OVA and recombinant GM-CSF induced the production of OVA-specific IgA in nasal ...
more infohttps://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-018-3591-3
Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T...  Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T...
Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T ... 2016) Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ ... We found that intranasal vaccination generated robust and durable tissue-resident effector and effector memory CD8+ T cell ... The generation of these antigen-experienced cells by intranasal vaccination resulted in earlier T cell responses, interferon ...
more infohttp://researchrepository.murdoch.edu.au/id/eprint/34844/
Effect of intranasal administration of norethisterone and progesterone on pituitary and gonadal function in adult male and...  Effect of intranasal administration of norethisterone and progesterone on pituitary and gonadal function in adult male and...
Effect of intranasal administration of norethisterone and progesterone on pituitary and gonadal function in adult male and ... Effect of intranasal administration of norethisterone and progesterone on pituitary and gonadal function in adult male and ... Intranasal spray of NET in adult cycling female monkeys between days 5 and 14 shortened the menstrual cycle ascribed to a ... The effect of intranasal spray of norethisterone (NET) [68-22-4] and progesterone (P) [57-83-0] on serum testosterone (T) [58- ...
more infohttp://eprints.iisc.ernet.in/14701/